Bispecific t cell engager - Open Access .click

Results 221 to 230 of about 5,563 (240)

Some of the next articles are maybe not open access.

Anti-PD-L1 × anti-CD3 bispecific T-cell engager-armed T cells can overcome immunosuppression and redirect T cells to kill breast cancer cells expressing PD-L1

International Immunopharmacology, 2023
Piriya Luangwattananun +2 more
exaly

Tumor flare with T-cell-engaging bispecific antibodies

Leukemia & Lymphoma
Carmelo Carlo-Stella +7 more
openaire +2 more sources

Application of Bispecific T Cells Engagers in Hematological Malignancy

MedScien
Over the past decade, it has played a significant role in immunology and is commonly used to combat malignant blood tumors. The product that has been invented and is the most successful one is blinatumomab. BiTEs are dual-specificity T-cell engagers composed of two linked antigen-binding variable fragments, and these fragments do not contain the ...
openaire +1 more source

Tetracyclines Enhance Anti-tumor T-Cell Responses Induced by a Bispecific T-Cell Engager

Biological and Pharmaceutical Bulletin, 2022
Yuki Noguchi, Yoko Yamamoto, Michinari Hirata +2 more
exaly

Bispecific NK-cell engager targeting BCMA elicits stronger antitumor effects and produces less proinflammatory cytokines than T-cell engager

Frontiers in Immunology, 2023
, Yuhang Fang, Zhigang Tian
exaly

GPRC5D-targeted bispecific bolsters T-cell-engager pipeline

Nature Reviews Drug Discovery, 2023
exaly

Bispecific dendritic-T cell engager potentiates anti-tumor immunity

Cell
Rony Dahan
exaly

Characterization of Bispecific T-cell Engager (BiTE®) Antibodies with a High-Capacity T-cell Dependent Cellular Cytotoxicity (TDCC) Assay

SLAS Discovery, 2015
exaly

A Transformable Supramolecular Bispecific Cell Engager for Augmenting Natural Killer and T Cell‐Based Cancer Immunotherapy

Advanced Materials
Yumiao Chen, Yinghao Ding, Zhimou Yang +2 more
exaly